Antimicrobial and Antifungal Study of Thiazolotriazolium Salts: in vivo Investigation, and Molecular Docking
Journal of Organic and Pharmaceutical Chemistry · 07.04.2026 · 23 (4) · 44-56
DOI: 10.24959/ophcj.25.344433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Organic and Pharmaceutical Chemistry, online erschienen am 07.04.2026. Verfasst von Nataliya I. Korol und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Three thiazolo[3,2-b][1,2,4]triazol-7-ium hexabromotellurates 1-3 were synthesized via the electrophilic heterocyclization of methallyl thioether precursors using a classical tellurium(IV) electrophilic reagent generated in situ from TeO2 and 1 M hydrobromic acid. The resulting salts were comprehensively screened for the antimicrobial activity against five clinically relevant pathogens: Staphylococcus aureus, Candida albicans, Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa. Biological assays revealed that compound 1 containing a 2-(4-pyridyl) substituent demonstrated the strongest activity profile, particularly against C. albicans (MIC = 15.625 μg mL-1) and E. coli (MIC = 31.25 μg mL-1). Compound 2, substituted with the 3-hydroxyphenyl moiety, also showed a significant antifungal efficacy, while compound 3 (with the 2-phenyl substituent) exhibited a relatively low activity. To rationalize these differences, the molecular docking was performed targeting MurB (UDP-N-acetylenolpyruvoylglucosamine reductase, PDB 1MBT) and DNA gyrase B (GyrB, PDB 4URO), two bacterial enzymes known to be essential for the viability of Gram-negative pathogens. The docking results confirmed the experimental data, showing strong π–π stacking and hydrogen bonding between compound 1 and the FAD-containing binding pocket of MurB. This work highlights the utility of the tellurium-induced annulation in producing biologically potent heterocycles and emphasizes the structure–activity relationships driven by substituents in position 2 of the fused scaffold.
Zitieren
APA
Korol, N. I., Pantyo, V. V., Bestritska, V. O., Avdeeva, K. A., Molnar-Babilya, D. I., Fizer, M. M., & Slivka, M. V. (2026). Antimicrobial and Antifungal Study of Thiazolotriazolium Salts: in vivo Investigation, and Molecular Docking. Journal of Organic and Pharmaceutical Chemistry, 23(4), 44-56. https://doi.org/10.24959/ophcj.25.344433
Vancouver
Korol NI, Pantyo VV, Bestritska VO, Avdeeva KA, Molnar-Babilya DI, Fizer MM, et al. Antimicrobial and Antifungal Study of Thiazolotriazolium Salts: in vivo Investigation, and Molecular Docking. Journal of Organic and Pharmaceutical Chemistry. 2026;23(4):44-56. doi:10.24959/ophcj.25.344433
BibTeX
@article{Korol2026,
author = {Korol, Nataliya I. and Pantyo, Valeriy V. and Bestritska, Victoriia O. and Avdeeva, Kamila A. and Molnar-Babilya, Dzhosiya I. and Fizer, Maksym M. and Slivka, Mykhailo V.},
title = {Antimicrobial and Antifungal Study of Thiazolotriazolium Salts: in vivo Investigation, and Molecular Docking},
journal = {Journal of Organic and Pharmaceutical Chemistry},
year = {2026},
volume = {23},
number = {4},
pages = {44--56},
doi = {10.24959/ophcj.25.344433}
}
EUVIMED